Crosslinked polymer nanocapsules for therapeutic, diagnostic, and theranostic applications.

PubMed ID: 32618433

Author(s): Sun H, Erdman W 3rd, Yuan Y, Mohamed MA, Xie R, Wang Y, Gong S, Cheng C. Crosslinked polymer nanocapsules for therapeutic, diagnostic, and theranostic applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Nov;12(6):e1653. doi: 10.1002/wnan.1653. Epub 2020 Jul 3. Review. PMID 32618433

Journal: Wiley Interdisciplinary Reviews. Nanomedicine And Nanobiotechnology, Volume 12, Issue 6, Nov 2020

Crosslinked polymer nanocapsules (CPNCs) are hollowed nanoparticles with network-like polymeric shells stabilized by primary bonds. CPNCs have drawn broad and significant interests as nanocarriers for biomedical applications in recent years. As compared with conventional polymeric nanoparticles systems without cavity and/or crosslinking architectures, CPNCs possess significant biomedical relevant advantages, including (a) superior structural stability against environmental conditions, (b) high loading capacity and ability for region-specific loading of multiple cargos, (c) tuneable cargo release rate via crosslinking density, and (d) high specific surface area to facilitate surface adsorption, modification, and interactions. With appropriate base polymers and crosslinkages, CPNCs can be biocompatible and biodegradable. While CPNC-based biomedical nanoplatforms can possess relatively stable physicochemical properties owing to their crosslinked architectures, various biomedically relevant stimuli-responsivities can be incorporated with them through specific structural designs. CPNCs have been studied for the delivery of small molecule drugs, genes, proteins, and other therapeutic agents. They have also been investigated as diagnostic platforms for magnetic resonance imaging, ultrasound imaging, and optical imaging. Moreover, CPNCs have been utilized to carry both therapeutics and bioimaging agents for theranostic applications. This article reviews the therapeutic, diagnostic and theranostic applications of CPNCs, as well as the preparation of these CPNCs, reported in the past decade. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease Implantable Materials and Surgical Technologies > Nanomaterials and Implants Diagnostic Tools > in vivo Nanodiagnostics and Imaging.

© 2020 Wiley Periodicals LLC.